Significance of the Plasma Lipid Profile in Cases of Carcinoma of Cervix: A Tertiary Hospital Based Study

  • Raju, Kalyani (Department of Pathology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research) ;
  • Punnayanapalya, Shruthi Suresh (Department of Pathology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research) ;
  • Mariyappa, Narayanaswamy (Department of Obstetrics and Gynecology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research) ;
  • Eshwarappa, Sumathi Mayagondanahalli (Department of Biochemistry, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research) ;
  • Anjaneya, Chandramouli (Department of Obstetrics and Gynecology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research) ;
  • Kai, Lee Jun (Department of Pathology, Sri Devaraj Urs Medical College, Sri Devaraj Urs Academy of Higher Education and Research)
  • Published : 2014.04.30


Aims: To study alterations of plasma lipid profiles in carcinoma cervix and to assess significance comparedwith controls in different histological grades and stages. Materials and Methods: Totals of 99 histopathologically diagnosed cases and 35 controls from a tertiary hospital situated in the southern part of India which caters the rural and semi-urban populations were considered for the study. Fasting blood samples were taken to analyze total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C) and low density lipoproteins cholesterol (LDL-C), for comparison of cases, grouped according to histological grades and stages, and controls. One way ANOVA was used for multiple group comparisons and the Student's t test (unpaired) for group wise comparisons. For all tests a 'p' value of 0.05 or less was considered as significant. Results: Out of 99 cases, most (n-39) were seen in the 40-49 year age group followed by 60-69 years (n-22). Serum TG significantly differed between cases and controls but without any relation to differentiation grade. The lipid profile parameters in various grades of cervical cancer were not statistically significant. Statistically significant increase of TC and LDL-C values was observed with increase in stage of the disease. Conclusions: The study showed TG is elevated in cervical cancer, and that TC and LDL-C are proportional to the spread of cancer as it increases from stage I to stage IV. An in-depth study of molecular changes in lipid metabolism in cervical cancer patients, enzymes/genes responsible and alterations in LDL receptors is necessary to provide information to decide whether the lipid profile has any diagnostic/prognostic role in cervical cancer.


  1. Tania M, Khan MA, Song Y (2010). Association of lipid metabolism with ovarian cancer. Current Oncology, 17, 6-11.
  2. Timovska Yu, Pivnyuk V, Todor I, Anikusko N, Chekhun V (2011). The spectrum of blood serum lipids in patients with breast cancer without metabolic syndrome. Exp Oncol, 33, 190-2.
  3. Young DS, Naito HK (1973). Estimation of serum cholesterol. In: Fundamentals of Clinical Chemistry. Ed. Tietz NW. W B Saunders, Philadelphia. Page, 79.
  4. Ozdemir BH, Akeali Z, Haberal M (2004). Hypercholesterolemia impairs angiogenesis in patients with breast carcinoma and therefore lowers the risk of metastases. Am J Clin Pathol, 122, 696-703.
  5. Naik PP, Ghadge MS, Raste AS (2006). Lipid profile in leukemia and Hodgkin’s disease. Indian J Clin Biochem, 21, 100-2.
  6. Nayak P, Nayak S, Darafsh MD (2010). Alteration in plasma lipid profile in precancerous conditions. J Nepal Dent Asso, 11, 40-5.
  7. Okonkwo CA, Amegor OF, Ogemuno OL (2011). Alterations in lipid profile of patients with advanced cervical cancer. J Home, [Epub ahead of print].
  8. Patel PS, Shah MH, Jha FP, et al (2004). Alterations in plasma lipid profile patterns in head and neck cancer and oral precancerous conditions. Indian J Cancer, 41, 25-31.
  9. Preetha A, Banerjee R, Hulgoi N (2007). Tensiometric profiles and their modulations by cholesterol: implications in cervical cancer. Cancer invest, 25, 172-81.
  10. Preetha A, Hulgoi N, Banerjee R (2005). Interfacial properties as biophysical markers of cervical cancer. Biomed Pharmacother, 59, 491-7.
  11. Raste AS, Naik PP (2000). Clinical significance of lipid; profile in cancer patients. Indian J Med Sci, 54, 435-41.
  12. Ravichandran P, Bhuvaragamurthy V, Govindasamy S (1996). Status of circulating lipid profile in human uterine cervical carcinoma before and after therapy. J Clin Biochem, 21, 219-25.
  13. Satija A. Cervical cancer in India (2013). South Asia Centre for Chronic Disease [Internet]. Available from:
  14. Singh S, Ramesh V, Premalatha B, Prashad KV, Ramadoss K (2013). Alteration in serum lipid profile patterns in oral cancer. J Nat Sci Biol Med, 4, 374-8.
  15. Gupta RK, Singh N (2013). Morinda citrifolia (Noni) alters oxidative stress marker and antioxidant activity in cervical cancer cell lines. Asian Pac J Cancer Prev, 14, 4603-6.
  16. Deshpande R, Mansara P, Suryavanshi S, Ghanekar RK (2013). Alpha-linolenic acid regulates the growth of breast and cervical cancer cell lines through regulation of NO release and induction of lipid peroxidation. J Molec Biochem, 2.
  17. Greene FL, Compton CC, Fritz AG, et al (2006). AJCC Cancer Staging Atlas. 6th edition. Chicago, Springer. p 249-58.
  18. Gupta RK, Patel AK, Kumari R, et al (2012). Interactions between oxidative stress, lipid profile and antioxidants in breast cancer: a case control study. Asian Pac J Cancer Prev, 13, 6295-8.
  19. Herbey II, Ivankova NV, Katkoori VR, Mamaevu OA (2005). Colorectal cancer and htpercholesterolemia: review of current research. Exp Oncol, 27, 166-78.
  20. International Agency for Research on Cancer, Globocan (2008). (Iarc), section of cancer information (30/10/2013).
  21. Kalyani R, Das S, Bindra Singh MS, Kumar HML (2010). Cancer profile in Kolar: a ten years study. Indian J Cancer, 47, 160-5.
  22. Laisupasin P, Thompat W, Sukarayodhin S, Somprom A, Sudjaroen Y (2013). Comparison of serum lipid profiles between normal controls and breast cancer patients. J Lab Physicians, 5, 38-41.
  23. Mehrotra R, Pandya S, Chaudhary AK, et al (2009). Lipid profile in oral submucous fibrosis. Lipids Health Dis, 8, 29.
  24. Misra JS, Srivastava S, Singh U, Srivastava AN (2009). Risk factors and Strategies for control of carcinoma cervix in India: hospital based cytological screening experience of 35years. Indian J Cancer, 46, 155-9.
  25. Buccolo G, David M (1973). Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem, 19, 476-82.
  26. Chawda JG, Jain SS, Patel HR, Chaduvula N, Patel K (2011). The relationship between serum lipid levels and the risk of oral cancer. Indian J Med Paediatr Oncol, 32, 34-7.
  27. Dabrowa AB, Hannam S, Rysz J, Banach M (2011). Malignancy associated dyslipidemia. Open Cardiovasc Med J, 5, 35-40.
  28. Denahcherp NM, Hijans AGM, Vos-janssen HE, Vantloar AP (1980). Clin Chem, 26, 1775.

Cited by

  1. The Comparison and Estimation of the Prognostic Value of Lipid Profiles in Patients With Prostate Cancer Depends on Cancer Stage Advancement vol.11, pp.6, 2017,